Cipla informs about press release

12 Dec 2019 Evaluate

Cipla has informed that it has enclosed press release dated 11th December, 2019 by Avenue Therapeutics Inc., USA, associate company of Cipla, titled 'Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol'.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1317.80 -2.55 (-0.19%)
30-Jan-2026 11:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1587.60
Dr. Reddys Lab 1222.00
Cipla 1317.80
Zydus Lifesciences 885.80
Lupin 2135.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×